Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL28198013 | 0.85 | KMT2A (0.34) | KMT2AMEN1CYP1A2RAB9AL3MBTL1 | |
| SCHEMBL4730278 | 0.76 | KMT2A (0.36) | KMT2AMEN1CYP1A2RAB9AL3MBTL1 | |
| SCHEMBL632902 | 0.75 | PKM (0.49) | RAB9AL3MBTL1ALDH1A1GSK3BNPC1 | |
| SCHEMBL13141391 | 0.74 | KMT2A (0.35) | KMT2AMEN1CYP1A2RAB9AL3MBTL1 | |
| SCHEMBL6723581 | 0.74 | ELANE (0.44) | KMT2AMEN1CYP1A2ALDH1A1SLC7A5 | |
| Hydrochloric Acid SCHEMBL27871149 | 0.73 | KMT2A (0.44) | KMT2AMEN1CYP1A2RAB9AL3MBTL1 | |
| SCHEMBL11389305 | 0.71 | FABP4 (0.37) | KMT2AMEN1CYP1A2RAB9AL3MBTL1 | |
| SCHEMBL6984283 | 0.70 | SLC7A5 (0.38) | KMT2AMEN1CYP1A2ALDH1A1SLC7A5 | |
| SCHEMBL3908066 | 0.70 | KMT2A (0.76) | KMT2AMEN1CYP1A2RAB9AL3MBTL1 | |
| SCHEMBL5725289 | 0.70 | POLB (0.46) | KMT2AMEN1CYP1A2RAB9AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118338897-A | Compositions and methods for providing health benefits in animals using amino acid blends | 雀巢产品有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-116546981-A | Compositions and methods using at least one glycine or derivative thereof and/or at least one N-acetylcysteine or derivative thereof and at least one thymol and/or carvacrol | 雀巢产品有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-116456965-A | Compositions and methods using at least one glycine or derivative thereof and at least one large neutral amino acid and/or cationic amino acid or precursor thereof | 雀巢产品有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-118338897-A | Compositions and methods for providing health benefits in animals using amino acid blends | 雀巢产品有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-117940774-A | Methods of using conjugated bile acids as biomarkers for detecting and/or quantifying mood disorders and/or mood disorder status improvement and improved methods and compositions thereof | 雀巢产品有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-116546981-A | Compositions and methods using at least one glycine or derivative thereof and/or at least one N-acetylcysteine or derivative thereof and at least one thymol and/or carvacrol | 雀巢产品有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-116456965-A | Compositions and methods using at least one glycine or derivative thereof and at least one large neutral amino acid and/or cationic amino acid or precursor thereof | 雀巢产品有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-101541783-B | pyridinonyl PDK1 inhibitors | SUNESIS PHARMACEUTICALS, INC. (US) | 2014-10-01 | — | — | CN | disclosed |
| CN-101541783-A | Pyridinonyl PDK1 inhibitors | SUNESIS PHARMACEUTICALS (US) | 2009-09-23 | — | — | CN | disclosed |
| EP-1289953-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2003-03-12 | — | — | EP | disclosed |
| EP-1289954-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2003-03-12 | — | — | EP | disclosed |
| EP-1289950-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2003-03-12 | — | — | EP | disclosed |
| EP-1289972-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001096304-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| WO-2001096303-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| WO-2001096323-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| WO-2001096296-A1 | SERINE PROTEASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |